Serina Therapeutics, Inc.SERNYSE
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-114.91%
↓ 131% below average
Average (34q)
374.69%
Historical baseline
Range
High:12937.50%
Low:-885.71%
Volatility
3689.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -114.91% |
| Q2 2025 | 770.59% |
| Q1 2025 | -21.43% |
| Q4 2024 | -200.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 100.00% |
| Q1 2024 | -100.65% |
| Q4 2023 | 12937.50% |
| Q3 2023 | 0.00% |
| Q2 2023 | -100.00% |
| Q1 2023 | 165.38% |
| Q4 2022 | 10.34% |
| Q3 2022 | -7.41% |
| Q2 2022 | 6.90% |
| Q1 2022 | 9.38% |
| Q4 2021 | -220.00% |
| Q3 2021 | -11.11% |
| Q2 2021 | -145.00% |
| Q1 2021 | 118.18% |
| Q4 2020 | -885.71% |
| Q3 2020 | 40.00% |
| Q2 2020 | -91.23% |
| Q1 2020 | -55.03% |
| Q4 2019 | 141.43% |
| Q3 2019 | 38.16% |
| Q2 2019 | 220.63% |
| Q1 2019 | -800.00% |
| Q4 2018 | -102.99% |
| Q3 2018 | -15.83% |
| Q2 2018 | 1108.70% |
| Q1 2018 | -92.28% |
| Q4 2017 | 37.96% |
| Q3 2017 | 272.41% |
| Q2 2017 | 100.00% |
| Q1 2017 | 0.00% |